Medikaloka Hermina PT (HEAL) — Capital Reinvestment Ratio
Latest as of June 2025:
1.96x
Medikaloka Hermina PT (HEAL) has a Capital Reinvestment Ratio of 1.96x as of June 2025, meaning it reinvests 2% of its operating cash flow (Rp225.37 Billion) in capital expenditures (Rp442.71 Billion). See Medikaloka Hermina PT free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.96x
Capex / Operating Cash Flow
Operating Cash Flow
Rp225.37 Billion
IDR
Capital Expenditures
Rp442.71 Billion
IDR
Data as of
Jun 2025
Most recent filing
Medikaloka Hermina PT Capital Reinvestment Ratio (2015–2024)
This chart tracks Medikaloka Hermina PT's Capital Reinvestment Ratio across 10 annual periods.
Annual Capital Reinvestment Ratio for Medikaloka Hermina PT (2015–2024)
Year-by-year Capital Reinvestment Ratio for Medikaloka Hermina PT from 2015 to 2024. For live market cap and broader valuation context, see Medikaloka Hermina PT market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (IDR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 2.01x | Rp1.14 Trillion | Rp2.28 Trillion | ▲ +66.3% |
| 2023 | 1.21x | Rp1.32 Trillion | Rp1.59 Trillion | ▼ -46.2% |
| 2022 | 2.24x | Rp503.58 Billion | Rp1.13 Trillion | ▲ +242.9% |
| 2021 | 0.65x | Rp1.86 Trillion | Rp1.21 Trillion | ▼ -17.2% |
| 2020 | 0.79x | Rp1.13 Trillion | Rp889.65 Billion | ▼ -21.5% |
| 2019 | 1.01x | Rp572.58 Billion | Rp575.94 Billion | ▼ -68.2% |
| 2018 | 3.16x | Rp241.67 Billion | Rp764.16 Billion | ▲ +111.2% |
| 2017 | 1.50x | Rp465.08 Billion | Rp696.31 Billion | ▲ +11.3% |
| 2016 | 1.34x | Rp362.85 Billion | Rp487.92 Billion | ▼ -24.0% |
| 2015 | 1.77x | Rp255.71 Billion | Rp452.66 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow